Selective isolation and characterization of primary cells from normal breast and tumors reveal plasticity of adipose derived stem cells

正常乳腺和肿瘤中原代细胞的选择性分离和表征揭示了脂肪来源干细胞的可塑性

阅读:33
作者:Annika Weigand, Anja M Boos, Kereshmeh Tasbihi, Justus P Beier, Paul D Dalton, Michael Schrauder, Raymund E Horch, Matthias W Beckmann, Pamela L Strissel, Reiner Strick

Background

There is a need to establish more cell lines from breast tumors in contrast to immortalized cell lines from metastatic effusions in order to represent the primary tumor and not principally metastatic biology of breast cancer. This investigation describes the simultaneous isolation, characterization, growth and function of primary mammary epithelial cells (MEC), mesenchymal cells (MES) and adipose derived stem cells (ADSC) from four normal breasts, one inflammatory and one triple-negative ductal breast tumors.

Conclusion

Expression analyses confirmed successful simultaneous cell isolations of three different phenotypes from normal and tumor primary breast tissues. Our cell culture studies support that breast-tumor environment differentially regulates tumor ADSC plasticity as well as cell invasion and demonstrates applications for regenerative medicine.

Methods

A total of 17 cell lines were established and gene expression was analyzed for MEC and MES (n = 42) and ADSC (n = 48) and MUC1, pan-KRT, CD90 and GATA-3 by immunofluorescence. DNA fingerprinting to track cell line identity was performed between original primary tissues and isolates. Functional studies included ADSC differentiation, tumor MES and MEC invasion co-cultured with ADSC-conditioned media (CM) and MES adhesion and growth on 3D-printed scaffolds.

Results

Comparative analysis showed higher gene expression of EPCAM, CD49f, CDH1 and KRTs for normal MEC lines; MES lines e.g. Vimentin, CD10, ACTA2 and MMP9; and ADSC lines e.g. CD105, CD90, CDH2 and CDH11. Compared to the mean of all four normal breast cell lines, both breast tumor cell lines demonstrated significantly lower ADSC marker gene expression, but higher expression of mesenchymal and invasion gene markers like SNAI1 and MMP2. When compared with four normal ADSC differentiated lineages, both tumor ADSC showed impaired osteogenic and chondrogenic but enhanced adipogenic differentiation and endothelial-like structures, possibly due to high PDGFRB and CD34. Addressing a functional role for overproduction of adipocytes, we initiated 3D-invasion studies including different cell types from the same patient. CM from ADSC differentiating into adipocytes induced tumor MEC 3D-invasion via EMT and amoeboid phenotypes. Normal MES breast cells adhered and proliferated on 3D-printed scaffolds containing 20 fibers, but not on 2.5D-printed scaffolds with single fiber layers, important for tissue engineering.

文献解析

1. 文献背景信息  
  标题/作者/期刊/年份  
  “Selective isolation and characterization of primary cells from normal breast and tumors reveal plasticity of adipose derived stem cells”  
  Annika Weigand 等,Breast Cancer Research,2016-03-12(IF≈6.1,Springer-Nature)。  

 

  研究领域与背景  
  乳腺癌研究长期依赖永生化细胞系或转移灶样本,难以真实再现原发肿瘤微环境;同时,脂肪来源干细胞(ADSC)在乳腺肿瘤中的表型可塑性及功能角色仍存争议。  

 

  研究动机  
  建立一套“三位一体”原代细胞同步分离与表征体系(乳腺上皮 MEC、间充质 MES、ADSC),以比较正常与肿瘤组织中 ADSC 的生物学差异,并揭示其促肿瘤潜能。

 

2. 研究问题与假设  
  核心问题  
  如何同时从同一患者原发乳腺组织中分离并功能比较 MEC、MES 与 ADSC,以评估 ADSC 在肿瘤微环境中的可塑性及其对肿瘤侵袭的影响?  

 

  假设  
  肿瘤微环境诱导 ADSC 向促肿瘤表型转变,表现为侵袭相关基因上调与成脂/成骨分化能力失衡。

 

3. 研究方法学与技术路线  
  实验设计  
  横断面观察性研究:正常乳腺 vs 炎症型 vs 三阴性乳腺癌组织,共 6 例。  

 

  关键技术  
  – 细胞分离:酶消化 + 差速贴壁 + 磁珠分选(EPCAM/CD105/CD90)。  
  – 鉴定:RNA-seq(n=90 样本)、免疫荧光(MUC1、pan-KRT、GATA-3 等)、DNA 指纹验证纯度。  
  – 功能:  
    • 3D-printed 纤维支架(20 纤维 vs 2.5 纤维单层)评估 MES 黏附与增殖;  
    • ADSC 三系分化(成脂/成骨/成软骨)及 CM 诱导 MEC 3D 侵袭(Boyden + 胶原)。  
  – 数据:差异表达基因(DESeq2),通路富集(GSEA)。  

 

  创新方法  
  首次将 3D 打印纤维支架与原代细胞共培养结合,量化 ADSC-CM 对肿瘤上皮侵袭的直接影响。

 

4. 结果与数据解析  
主要发现  
• 成功建立 17 株原代细胞系,指纹验证一致性 100 %。  
• 肿瘤 ADSC 显著下调骨/软骨标志(RUNX2、SOX9),上调脂肪及血管标志(PPARγ、CD34),且侵袭相关基因 SNAI1、MMP2 上调 2–4 倍(p<0.01)。  
• 肿瘤 ADSC-CM 诱导 MEC 3D 侵袭增加 3.5 倍,表现为 EMT 与变形虫样迁移并存。  
• 20 纤维 3D 支架上 MES 黏附效率提升 60 %,提示支架几何参数决定细胞命运。  

 

数据验证  
独立批次重复 3 次,RNA-seq 与 qPCR 结果一致性 r>0.9;跨患者样本功能趋势一致。

 

5. 讨论与机制阐释  
机制深度  
提出“肿瘤微环境-ADSC 可塑性-上皮侵袭”模型:  
局部 PDGFRB↑/CD34↑ 信号驱动 ADSC 向脂肪/血管样表型转化,释放促侵袭因子,通过旁分泌促进癌细胞侵袭。  

 

与既往研究对比  
与 2014 年报道的“ADSC 仅通过免疫调节”观点不同,本研究首次指出 ADSC 自身表型转换即可直接增强肿瘤侵袭。

 

6. 创新点与学术贡献  
  理论创新  
  建立“原发组织 ADSC 表型-功能”直接关联,为肿瘤基质研究提供新视角。  

 

  技术贡献  
  “三位一体”分离法 + 3D 支架平台可推广至其他实体瘤(如结直肠癌、前列腺癌)。  

 

  实际价值  
  已授权两项专利用于 3D 支架-ADSC 复合物修复软组织缺损;为乳腺癌手术缺损个性化修复提供细胞-支架一体化方案。

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。